Aquatic Capital Management’s Regencell Bioscience RGC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-2,058
Closed -$12.5K – 1632
2026
Q2
$12.5K Buy
+2,058
New +$49.4K ﹤0.01% 1203

Other funds holding RGC

Aquatic Capital Management's RGC Position: Q3 2026 in Review

Aquatic Capital Management sold out of Regencell Bioscience (RGC) in Q3 2026, closing a stake of 2,058 shares — an estimated $12.5K sold.

Aquatic Capital Management first reported a position in RGC in Q2 2026 and held it in 1 quarter. The position peaked at $12.5K in Q2 2026. 31 funds tracked by Wall St. Rank hold RGC as of Q3 2026.

  • Aquatic Capital Management reported no remaining Regencell Bioscience position as of Q3 2026 after selling out during the quarter.
  • Aquatic Capital Management sold 2,058 Regencell Bioscience shares in Q3 2026, an estimated $12.5K.
  • Aquatic Capital Management first reported a position in Regencell Bioscience in Q2 2026 and held it in 1 quarter.
  • Aquatic Capital Management's Regencell Bioscience position peaked at $12.5K in Q2 2026.
  • 31 funds tracked by Wall St. Rank held Regencell Bioscience as of Q3 2026.

Based on Aquatic Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.